Corticotropin-releasing factor
著者
書誌事項
Corticotropin-releasing factor
(Ciba Foundation symposium, 172)
J. Wiley, 1993
大学図書館所蔵 全11件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
"Symposium on Corticotropin-Releasing Factor, held at the Ciba Foundation, London, 10-12 March 1992."
Editors: Derek J. Chadwick, Joan Marsh and Kate Ackrill
"A Wiley-interscience publication"
Includes bibliographical references and index
内容説明・目次
内容説明
Corticotropin-Releasing Factor Chairman: Wylie Vale 1993 Corticotropin-releasing factor (CRF) is synthesized in the hypothalamus and regulates the secretion of adrenocorticotropic hormone (ACTH) from the posterior pituitary. After the discovery of CRF's structure and ACTH-releasing activity in 1981, it became apparent that CRF has a variety of additional effects, including activation of the sympathetic nervous system and regulation of behavioural responses to stress in animals. This symposium brought together experts working on CRF in a variety of systems, with the aim of providing a coherent picture of the role this peptide plays in the control and coordination of the response to stress-inducing situations. The location and connections of CRF neurons are described, and the involvement of certain CRF pathways in stress responses and in clinical disorders is assessed. The synthesis and release of CRF and the intracellular signals and genetic mechanisms which regulate these processes in normal conditions and in response to stress are discussed in depth; the relationship between cytokines and CRF is featured particularly.
CRF's effects on the cardiovascular system, on the autonomic nervous system and on behaviour, and their relevance to stress responses are covered. There is now considerable evidence that overactivity in CRF systems is associated with depressive illness and anxiety disorders. Results of laboratory and clinical studies are described, and the significance of CRF in the origin of such affective disorders is debated. The high levels of CRF observed in the latter stages of human pregnancy and the role of the CRF-binding protein in preventing the expected pathological effects of raised CRF levels are discussed, CRF's peripheral anti-inflammatory actions are also considered. Related Ciba Foundation Symposia: No. 168 Functional anatomy of the neuroendocrine hypothalamus Chairman: Stafford Lightman 1992 ISBN 0 471 93440 2 No. 166 Cocaine: scientific and social dimensions Chairman: Griffith Edwards 1992 ISBN 0 471 93179 9 No. 153 Steroids and neuronal activity Chairman: M. A. Simmonds 1990 ISBN 0 471 92689 2
目次
Partial table of contents: The Functional Neuroanatomy of Corticotropin-Releasing Factor (P. Sawchenko, et al.). Second Messenger Regulation of mRNA for Corticotropin-Releasing Factor (J. Majzoub, et al.). Corticotropin-Releasing Factor and Its Binding Protein in Human Plasma (P. Lowry). Expression of Corticotropin-Releasing Factor mRNA in Response to Stress (S. Lightman & M. Harbuz). Mechanisms Mediating the Effects of Cytokines on Neuroendocrine Functions in the Rat (C. Rivier & S. Rivest). Peripheral Anti-Inflammatory Actions of Corticotropin-Releasing Factor (E. Wei, et al.). The Role of Corticotropin-Releasing Factor in Behavioral Responses to Stress (G. Koob, et al.). Indexes.
「Nielsen BookData」 より